Antoni

Gual

Dr Antoni Gual is a psychiatrist, Emeritus Researcher at IDIBAPS, and former Head of the Addictions Unit at the Neurosciences Institute, Clínic Hospital, University of Barcelona, Spain, and also acts as Alcohol Consultant at the Health Department of Catalonia. He has coordinated several EU funded projects in the field of addictions and has also been PI of several pharmacological clinical trials. He has published more than 150 articles in peer reviewed journals and edited several books.

He is Vicepresident of the International Network on Brief Interventions for Alcohol Problems (INEBRIA), past-President of the European Federation of Addiction Scientific Societies (EUFAS) and past-President of the Spanish Scientific Society for the Study of Alcohol and Alcoholism.

Over the years Dr Gual has been involved in several clinical trials for the treatment of addictions, including being PI in pivotal Spanish studies on acamprosate, sodium oxibate, and in one trial of Nalmefene (Esense 2). In the field of brief interventions, he has been involved in the development of the Catalan program on brief interventions in PHC since its creation in 1995, and has developed also brief motivational interventions for use in the Emergency Room. He has contributed to running several EU-funded studies focusing on Brief Interventions (SMART, Bistairs, EWA, SCALA); and been project coordinator in European projects on brief interventions, e-health and public health (PHEPA, AMPHORA, ODHIN, ALICE RAP, DEEP SEAS).